Interleukin-1β and interleukin-1 receptor inhibitor gene cluster polymorphisms in patients with coronary artery disease after percutaneous angioplasty or coronary artery bypass grafting

Kardiologia Polska

Volumn 67, Issue 6, 2009, Pages 601-610

  Rechciński, Tomasz ^a   Grebowska, Aneta ^b   Kurpesa, Małgorzata ^a   Sztybrych, Marta ^b   Peruga, Jan Z ^a   Trzos, Ewa ^a   Rudnicka, Wiesława ^b   Krzemińska Pakuła, Maria ^a   Chmiela, Magdalena ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

CABG; Coronary artery disease; Gene polymorphism; Interleukin 1 ; Percutaneous angioplasty

Indexed keywords

DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; IL1RN PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; ANGIOCARDIOGRAPHY; CORONARY ARTERY BYPASS GRAFT; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 67649639115     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sorensen TI, Nelson GG, Anderson PK, et al. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727-732 (Pubitemid 18090256)
2. Fischer M, Mayer B, Baessler A, et al. Familial aggregation of left main coronary artery disease and future risk of coronary events in asymptomatic siblings of affected patients. Eur Heart J 2007; 20: 2432-2437 (Pubitemid 47614292)
3. Ambroziak M, Budaj A. Genetic factors in pathogenesis of coronary artery disease in the young. Kardiol Pol 2007; 65: 71-78
4. Rechciński T, Grȩbowska A, Kurpesa M, et al. CD14 gene polymorphism 159 C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases. Kardiol Pol 2007; 65: 237-244 (Pubitemid 46955091)
5. Edfeldt K, Bennet AM, Eriksson P, et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004; 25: 1447-1453 (Pubitemid 39078252)
6. Galea J, Armstrong JA, Gadson PA, et al. Interleukin-1β in coronary arteries of patients with ischaemic heart disease. Arterioscler Thromb Vasc Biol 1996; 16: 1000-1006 (Pubitemid 26266899)
7. Libby P, Ordovas JM, Birinyi LK, et al. Inductible interleukin-1 expression in human vascular smooth muscle cells. J Clin Invest 1986; 78: 1432-1438 (Pubitemid 17219503)
8. Bochner BS, Luscinskas FW, Gimbrone MA Jr, et al. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1 activated endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med 1991; 173: 1553-1557
9. Bevilacqua MP, Pober S, Majeau GR, et al. Interleukin-1 induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618-623 (Pubitemid 14052522)
10. Mans JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine IL-1ra. Gastroenterology 1994; 106: 637-642
11. McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 polymorphism. Arthritis Rheum 1995: 38: 221-228
12. Chmiela M, Kowalewicz-Kulbat M, Miszczak A, et al. A link between Helicobacter pylori and/or Chlamydia spp. infections and atherosclerosis. FEMS Immunol Med Microbiol 2003; 36: 187-192 (Pubitemid 36556038)
13. Grȩbowska A, Rechciński T, Ba̧k-Romaniszyn L, et al. Potential role of LPS in the outcome of Helicobacter pylori related diseases. Pol J Microbiol 2006; 55: 23-30.
14. Hannan EL, Racz MJ, Walford G. Long-term outcomes of coronary artery by-pass grafting versus stent implantation. N Eng J Med 2005; 352: 2174-2184 (Pubitemid 40727084)
15. Rad R, Prinz Ch, Neu B, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003; 188: 272-281 (Pubitemid 36898160)
16. McGuire DK, Anstrom KJ, Peterson ED. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. Circulation 2003; 107: 1864-1870 (Pubitemid 36444126)
17. Francis SE, Camp NJ, Dewberry RM, et al. Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease. Circulation 1999; 99: 861-866 (Pubitemid 29094297)
18. Vohnout B, Di Castelnuovo A, Trotta R, et al. Interleukin-1 gene cluster polymorphism and risk of coronary artery disease. Haematologica 2003; 88: 54-60. (Pubitemid 36168855)
19. Zhang YM, Zhong LJ, He BX, et al. The correlation between polymorphism at position -511C/T in the promoter region of interleukin 1B and the severity of coronary heart disease. Zhonghua Yi Xue Chuan Xeu Za Zhi 2006; 23: 86-88
20. Francis SE, Camp NJ, Burton AJ, et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 2001; 86: 336-340 (Pubitemid 32800088)
21. Danis VA, Millington M, Hyland VJ, et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1ra) gene polymorphism. Clin Exp Immunol 1995; 199: 303-310
22. Dewberry RM, Holden H, Crossman DC, et al. Interleukin-1 receptor antagonist (IL-1ra) in human endothelial cells and diseased coronary arteries. Arterioscler Thromb Vasc Biol 2000; 20: 2394-2400 (Pubitemid 30825073)
23. Latkovskis G, Licis N, Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 2004; 31: 207-213 (Pubitemid 39315139)
24. Momiyama Y, Hirano R, Taniguchi H, et al. Effects of interleukin-1 gene polymorphism on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 2001; 38: 712-717 (Pubitemid 32835741)
25. Iacoviello L, Di Castelnuovo A, Gattone M, et al. Polymorphism of the Interlekin-1β Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In Vitro. Arterioscler Thromb Vasc Biol 2004; 25: 222-227 (Pubitemid 40054280)
26. Wen AQ, Wang J, Feng K, et al. Effects of haplotypes in the interleukin 1β promoter on lipopolysaccharide-induced interleukin 1β expression. Shock 2006; 26: 25-30. (Pubitemid 44297002)
27. Doria A, Wojcik J, Xu R, et al. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. JAMA 2008; 300: 2389-2397
28. Drzewoski J, Śliwińska A, Przybyłowska K, et al. Gene polymorphism and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary artery disease. Kardiol Pol 2008; 66: 1042-1048